Objective: To explore the effects of dexmedetomidine on controlled analgesic efficacy and systemic inflammatory response in sufentanil after operation.Methods: 160 patients who would have thoracotomy were selected and divided into four groups:high dose group(1.5ug/kg dexmedetomidine+100 ugsufentanil+4 mg tropisetron,H), moderate dose group(1ug/kg dexmedetomidine+100 ugsufentanil+4 mg tropisetron,M), low dose group(0.5ug/kg dexmedetomidine+100 ugsufentanil+4 mg tropisetron,L), and sufentanilonly group(150 ugsufentanil+4 mg tropisetron,C). The VAS score and RAMSAY score at moments of T1(0.5 h), T2(2 h), T3(6 h), T4(12 h) and T5(24 h) after surgery were observed. The level of CRP, TNF-a and IL-10 in patients' blood samples and adverse reactions during the 48 hours after surgery were detected. Results: Compared with C group(sufentanil group), the VAS score in group H(high dose group) at T2-5, in group M(moderate dose group) at T3-5, in group L(low dose group) at T3-4 were significantly decreased, and the Ramsay score in L group at T3-4, in M group at T3-5, in H group at T2-5 were significantly increased; But, compared to group C, in the three groups, the level of CRP, TNF-a at T2-5 were significantly decreased, and the level of IL-10 was significantly increased, The differences were both statistically significant. And the adverse reaction rate in group H was 52.5%, in group C was 47.5%, which was significantly higher than that in group M(12.5%) and group L(10%), and the difference was statistically significant.Conclusion: Using dexmedetomidine in patients undergoing thoracotomy significantly improves the effect of sufentanil mediated PCIA, and the higher dose of dexmedetomidine, the quicker analgesic effect. But the appropriate dose reduction can ensure reduced adverse reactions while ensuring the the analgesic effect, dexmedetomidine 1 g/kg being the ideal dose. |
[1] KITAMURA H, KITAYAMA M, TANIMO T, et al. Successful anesthetic management in a patient with chronic obstructive pulmonary disease(COPD) using Dexmedetomidine and combined spinal-epidural anesthesia for low anterior resection of the rectum[J].Masui,2012, 61(8):840.
[2] 卞新荣,齐敦益,刘金东,等. 盐酸右美托咪定辅助舒芬太尼在腹腔镜全子宫切除术后镇痛中的应用[J].徐州医学院学报, 2015,35(3):191-192.
[3] READE MC, BAILEY M, BELLOMO R. Dexmedetomidine to reduce intubation time in patients with agitated delirium-reply[J].JAMA,2016,316(7):773-774.
[4] 李丽妍,张兴安,黄金平. 不同剂量右美托咪定对老年患者下肢手术后舒芬太尼自控静脉镇痛效应的影响[J].广州医学院学报, 2016, 44(2):13-17.
[5] 卢增停,杨纲华,何绮桃,等. 地佐辛对小儿七氟烷复合麻醉苏醒期躁动及血流动力学的影响[J].中国新药与临床杂志, 2014,33(4):260-262.
[6] 徐凯,郑文泽,胡毅平. 右美托咪定预防神经外科手术全麻苏醒期躁动的临床观察[J].重庆医学,2014,43(1):120-121.
[7] 杨强,常玉林,刘香阁,等. 右美托咪定联合氟比洛芬酯对开胸手术患者全身麻醉苏醒期躁动的影响[J].中华医学杂志, 2013,93(39):3155-3156.
[8] 石念军,张维霞,张昊,等. 右美托咪定对小儿全凭静脉麻醉苏醒期躁动的影响[J].中华实验外科杂志,2013,30(12):2736-2737.
[9] BEGON S, PICKERING G, ESCHALIER A, et al. Role of spinal NMDA receptors, protein kinase C and nitric oxide synthase in the hyperalgesia induced by magnesium deficiency in rats[J].Br J Pharmacol, 2001, 134(6):1227-1236.
[10] 王依慰, 陈春龙,支亦博,等. 瑞芬太尼与舒芬太尼全身麻醉后对患者苏醒质量影响的Meta分析[J].医学研究生学报, 2016,29(2):170-177.
[11] 郑勇萍,郭伟,张宗泽,等. 不同剂量的右美托咪定对全麻开胸手术患者苏醒期躁动及炎性细胞因子的影响[J].武汉大学学报:医学版,2013,34(1):113-117.
[12] SRIAVSTAYA V K, AGRAWAL S, KUMAR S, et al. Comparison of dexmedetomidine, propofol and midazolam for short-term sedation in postoperatively mechanically ventilated neurosurgical patients[J].J Clin Diagn Res, 2014, 8(9):4-7.
[13] JANG Y E, KIM Y C, YOON H K, et al. A randomized controlled trial of the effect of preoperative dexmedetomidine on the half maximal effective concentration of propofol for successful i-gel insertion without muscle relaxants[J].J Anesth,2014, 29(3):1-8.
[14] BALKANAY O O, GOKSEDEF D, OMEROGLU S N, et al. The dose-related effects of Dexmedetomidine on renal functions and serum neutrophil gelatinase-associated lipocalin values after coronary artery bypass grafting:a randomized, triple-blind, placebo-controlled study[J].Interact Cardiovasc Thorac Surg,2014,20(2):209-214. |